Oberland Capital

What is Oberland Capital?

Oberland Capital is a private investment firm dedicated to the healthcare industry, providing versatile financing solutions to a global clientele. Founded in 2013 and headquartered in New York, the firm manages an estimated $3.2 billion in assets.

Oberland Capital excels in crafting specialized investment deals tailored to the specific needs of its partners, with an emphasis on transforming patient care through funding innovation.

The investment size ranges from $50 million up to $300+ million, showcasing its ability to support significant growth opportunities in the sector. The firm’s strategic investment approach includes the monetization of royalty streams, purchasing future product revenues, creating project-based financing structures, and making traditional debt and equity investments.

Their expertise lies in understanding the unique challenges of product development and commercialization in the life sciences, leveraging a team with a deep knowledge base that encompasses scientific, operational, and financial aspects. Oberland Capital’s global track record underscores its familiarity with local legal, tax, and accounting nuances, enabling it to deploy creative and flexible capital solutions across different geographies.

With 25 team members, Oberland Capital emphasizes collaboration with management teams to forge long-term investment structures that align with partners' strategic and financial goals. Their investments aim to accelerate the development and commercialization of healthcare products, with the intent to create value for transaction partners and improve patient outcomes worldwide.